# Xeris Biopharma Holdings, Inc.: Form 8-K, filed Apr 21, 2026

- Company: [Xeris Biopharma Holdings, Inc.](/companies/xers.md) (CIK 1867096)
- Form: 8-K
- Filed: 2026-04-21
- Accepted by EDGAR: Apr 21, 2026, 16:27 ET
- Period: 2026-04-20
- Accession: 0001867096-26-000020
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1867096/000186709626000020/xers-20260420.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1867096/000186709626000020/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1867096/000186709626000020/xers-20260420.htm

Filed Apr 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001867096-26-000020. Last ingested by Listed: Nov 6, 2026, 17:33 ET. No prices; not investment advice.
